ClinVar Miner

Submissions for variant NM_002880.4(RAF1):c.782C>G (p.Pro261Arg)

dbSNP: rs397516828
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000037706 SCV000061368 pathogenic Noonan syndrome 2016-02-17 criteria provided, single submitter clinical testing proposed classification - variant undergoing re-assessment, contact laboratory
GeneDx RCV000159077 SCV000209020 pathogenic not provided 2022-02-21 criteria provided, single submitter clinical testing Not observed in large population cohorts (gnomAD); Missense variants in this gene are often considered pathogenic (HGMD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in an individual with Noonan syndrome in the published literature (van Trier et al., 2015); This variant is associated with the following publications: (PMID: 30692697, 24803665, 28777121, 25862627, 26266034, 30384889, 32668031, 32981126, 24957944, 9689060, 15520807, 29493581, 19020799)
Eurofins Ntd Llc (ga) RCV000159077 SCV000333074 pathogenic not provided 2015-07-14 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000590070 SCV000698127 likely pathogenic RASopathy 2017-07-10 criteria provided, single submitter clinical testing Variant summary: The RAF1 c.782C>G (p.Pro261Arg) variant involves the alteration of a highly conserved nucleotide. 4/4 in silico tools predict a damaging outcome for this variant (SNPsandGO not captured due to low reliability index). This variant is absent in 121388 control chromosomes and has been reported in the literature in at least 2 Noonan Syndrome patients, one in whom the variant was absent in both parents (assumed de novo [Ratola_2015, VanTrier_2015]). Other variants affecting the same codon (Pro261Ala, Pro261Leu) have been classified as pathogenic/likely pathogenic by our lab, indicating the variant to be located in a mutational hotspot. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as pathogenic. Taken together, this variant is classified as likely pathogenic.
Labcorp Genetics (formerly Invitae), Labcorp RCV000590070 SCV000829989 pathogenic RASopathy 2022-11-09 criteria provided, single submitter clinical testing This missense change has been observed in individual(s) with Noonan syndrome (NS) (PMID: 25862627, 26266034, 28777121). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 261 of the RAF1 protein (p.Pro261Arg). ClinVar contains an entry for this variant (Variation ID: 40606). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Pro261 amino acid residue in RAF1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17603482, 17603483, 20683980, 21784453, 22465605). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RAF1 protein function.
Genome Diagnostics Laboratory, The Hospital for Sick Children RCV001813268 SCV002060441 likely pathogenic Noonan syndrome and Noonan-related syndrome 2017-04-10 criteria provided, single submitter clinical testing
DASA RCV000277865 SCV002318972 pathogenic Noonan syndrome 5 2022-03-25 criteria provided, single submitter clinical testing The c.782C>G;p.(Pro261Arg) missense change has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 40606; PMID: 28777121; 26266034; 25862627; 22824796; 22465605) -PS4. The variant is located in a mutational hot spot and/or critical and well-established functional domain (PMID: 22824796; 22465605) - PM1. This variant is not present in population databases (rs397516828- gnomAD; ABraOM no frequency - http://abraom.ib.usp.br.) - PM2. Pathogenic missense variant in this residue have been reported (ClinVar ID: 120246) - PM5. The variant was assumed de novo, but without confirmation of paternity and maternity (PMID: 26266034) - PM6. Missense variant in RAF1 that has a low rate of benign missense variation and in which missense variants are a common mechanism of disease - PP2. Multiple lines of computational evidence support a deleterious effect on the gene or gene product - PP3. In summary, the currently available evidence indicates that the variant is pathogenic
Baylor Genetics RCV000277865 SCV000854623 pathogenic Noonan syndrome 5 2018-11-18 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.